Ajooni Biotech Limited — Board Meeting, 14-08-2025: Outcome of Board Meeting

Ajooni Biotech has announced a board meeting where it approved the financial results for the quarter ended June 30, 2025. The company reported revenue from operations of ₹31.27 crore and a net profit of ₹0.78 crore for the quarter. In a key strategic move, the board also approved the re-appointment of Mr. Gursimran Singh as Whole-time Director for a period of five years, pending shareholder approval. This leverages his 15+ years of experience in animal husbandry and agriculture, including his eight-year tenure as CEO.